All filters
Abstracts
Global elimination of hepatitis C: meeting the World Health Organization’s 2030 goal
J. Calleja
Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Short Chain Fatty Acids Delay the Pathogenesis of Hepatitis B Virus-Associated Hepatocellular Carcinoma in an HBx transgenic mouse model
M. FeitelsonÂ
Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Comparative analysis of hepatitis B virus serologic profiles and biochemical markers with viral loads in Ondo, Nigeria.
M. Odimayo
Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Viral hepatitis B and C seroprevalence among at risk population in Taraba state: a seroprevalence study
A. Lamiya
Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Seroprevalence of viral hepatitis among health care workers (HCWS) in Taraba state, Nigeria
O. Tiwah John
Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Seroprevalence of hepatitis B surface antigen (HBsAG) and hepatitis C antibodies (HCVAb) among hemodialysis patients at the Yaounde General Hospital, Cameroon.
R. Kamga Wouambo
Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
High seroprevalence of viral hepatitis among animal handlers in Abeokuta, Nigeria
A. Oluremi
Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Sustainability of immune response to hepatitis B virus vaccination three years after vaccination among HIV-1 infected and uninfected adults in Kenya
R. Kamoni
Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Achieving sustained viral response (SVR) – is it a motivator for longterm positive lifestyle changes among people affected by VHC?
A. Schweitzer
Reviews in Antiviral Therapy & Infectious Diseases 11, 2020 Â
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Co-located treatment verus co-located care coordination to engage people who inject drugs in HCV care at a syringe service program: preliminary results from the accessible care randomized clinical trial
B. Eckhardt
Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Simplified HCV treatment model in primary healthcare in the country of Georgia
E. DolmazashviliÂ
Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Depist’c pharma an innovative outreach HCV screening project in pharmacy for drugs users and general population
A. Remy
Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Slidesets
Update on Hepatitis Delta Therapy - Robert Gish MD, FAASLD, AGAF, FAST
Presented at:
International Workshop on HBV Cure 2020
Slidesets
Update on New Antiviral Targets –non –Capsid Inhibitors - Man-Fung YuenMBBS, MD, PhD, DSc
Presented at:
International Workshop on HBV Cure 2020
Slidesets
Update on New Immuno Modulators - Adam Gehring PhD
Presented at:
International Workshop on HBV Cure 2020
Slidesets
Update on Novel Combination Strategies - Marion Peters MD
Presented at:
International Workshop on HBV Cure 2020
Slidesets
Update on New Antiviral Targets Core Capsid Inhibitors (CpAMs) - Kosh Agarwal BMedSci (Hons) MD FRCP
Presented at:
International Workshop on HBV Cure 2020
Videos
Safety Monitoring for Investigational HBV Drugs and Discontinuation of HBV Therapy - Poonam Mishra MD, MPH, FAASLD
Presented at:
International Workshop on HBV Cure 2020
Videos
Toxicity in new and established HBV compounds - Jordan Feld, MD, MPH
Presented at:
International Workshop on HBV Cure 2020
Videos
How to interpret flares in HBV trials with novel agents - Pietro Lampertico, MD, PhD
Presented at:
International Workshop on HBV Cure 2020
Videos
Rationale for including immune tolerant and low viral load patients in new drug trials placeholder - Henry Lik Yeun Chan
Presented at:
International Workshop on HBV Cure 2020
Videos
Potential of new combinations to achieve functional cure for Chronic Hepatitis B - Fabien Zoulim, MD, PhD
Presented at:
International Workshop on HBV Cure 2020
Slidesets
Safety Monitoring for Investigational HBV Drugs and Discontinuation of HBV Therapy - Poonam Mishra MD, MPH, FAASLD
Presented at:
International Workshop on HBV Cure 2020